Late Relapses following High Dose Chemotherapy and Autologous Stem Cell Transplant in Patients with Diffuse Large B Cell Lymphoma in the Rituximab Era

Abstract Background The standard of care for diffuse large B cell lymphoma (DLBCL) relapsing after front line therapy is high dose chemotherapy and autologous stem cell transplant (ASCT). Evidence suggests that early relapses (i.e. within 1 year) following this approach portends exceptionally poor o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2016
Hauptverfasser:	Hunter, Bradley D, Herr, Megan, Meacham, Philip J, Barlaskar, Ferdous, Evans, Andrew G, Burack, W. Richard, Liesveld, Jane L, Becker, Michael W, Milner, Laurie A, Constine, Louis, Dhakal, Sughosh, Barr, Paul M, Friedberg, Jonathan W, Casulo, Carla
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology, Oncology and Palliative Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!